Orlando FL 溃疡性结肠炎临床试验
23项针对 溃疡性结肠炎的研究正在 Orlando及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Site US-026, Orlando
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · 距离 16 英里
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
招募中2 期
- Site 007, Kissimmee · 距离 16 英里
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
招募中1/2 期欢迎健康志愿者
- Xencor Investigative Site, Kissimmee · 距离 16 英里
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
招募中2 期
- Clinical Research of Osceola, LLC, Kissimmee · 距离 16 英里
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
招募中2 期
- AdventHealth Orlando ( Site 1074), Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- AdventHealth Orlando, Orlando
- Clinical Research of Osceola, Kissimmee · 距离 16 英里
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
招募中2 期
- Digestive and Liver Center of Florida, Orlando
- Clinical Research of Osceola, Kissimmee · 距离 16 英里
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
招募中4 期
- Endoscopic Research Inc, Orlando
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Clinical Research of Osceola - Site Number: 8400013, Kissimmee · 距离 16 英里
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
招募中4 期
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · 距离 16 英里
Confirmatory Clinical Study in Active Ulcerative Colitis
招募中2 期
- Orlando Gastroenterology, P.A., Orlando
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
招募中2 期
- Primary Care of Osceola, Kissimmee · 距离 16 英里
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Orlando Health, Inc. - Site Number: 8400084, Orlando
- AdventHealth Orlando - Site Number: 8400070, Orlando
- Clinical Research of Osceola - Site Number: 8400013, Kissimmee · 距离 16 英里
- 以及另外 1 项
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
招募中
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
招募中观察性研究
- AdventHealth, Orlando
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Orlando Health Digestive Health Institute, Orlando
- AdventHealth Orlando, Orlando
- Novum Research, LLC, Clermont · 距离 24 英里
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
招募中观察性研究
- Orlando Health/Digestive Health Institute, Orlando
- Digestive and Liver Center of Florida Kissimmee, Kissimmee · 距离 16 英里
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
招募中2 期
- Arnold Palmer Hospital - Center for Digestive Health and Nutrition, Orlando
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
招募中2 期
- Investigational Site Number: 8400030, Kissimmee · 距离 16 英里
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
招募中2 期
- Mirador Therapeutics Selected Site, Orlando
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
招募中
- Orlando Health, Orlando
其他城市的 溃疡性结肠炎试验
- New York City, NY24 项研究
- Miami, FL22 项研究
- Houston, TX18 项研究
- San Antonio, TX16 项研究
- San Diego, CA16 项研究
- Tacoma, WA15 项研究
- Chicago, IL15 项研究
- Tyler, TX14 项研究
- St. Louis, MO14 项研究
- Colorado Springs, CO14 项研究
- Los Angeles, CA13 项研究
- Washington, DC12 项研究
Orlando的其他研究
- 非小细胞肺癌44 项研究
- 转移性癌症29 项研究
- 肥胖症29 项研究
- 癌症（所有类型）25 项研究
- 阿尔茨海默病25 项研究
- 超重25 项研究
- 2型糖尿病24 项研究
- 乳腺癌23 项研究
- 卵巢癌22 项研究
- 肺癌21 项研究
- 重度抑郁症19 项研究
- 结直肠癌19 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月30日。每项研究自行设定入选标准，由研究团队决定谁能参与。